Castration Resistant Prostate Carcinoma clinical trials

Explore recruiting castration resistant prostate carcinoma clinical trials.

Recruiting castration resistant prostate carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Castration Resistant Prostate Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First in human study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration resistant prostate carcinoma

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Castration Resistant Prostate Carcinoma trials by city

Castration Resistant Prostate Carcinoma in Toronto Castration Resistant Prostate Carcinoma in Vancouver Castration Resistant Prostate Carcinoma in Montreal Castration Resistant Prostate Carcinoma in Calgary Castration Resistant Prostate Carcinoma in Edmonton Castration Resistant Prostate Carcinoma in Ottawa Castration Resistant Prostate Carcinoma in Winnipeg Castration Resistant Prostate Carcinoma in Quebec City Castration Resistant Prostate Carcinoma in Hamilton Castration Resistant Prostate Carcinoma in Kitchener Castration Resistant Prostate Carcinoma in London Castration Resistant Prostate Carcinoma in Halifax Castration Resistant Prostate Carcinoma in New York Castration Resistant Prostate Carcinoma in Los Angeles Castration Resistant Prostate Carcinoma in Chicago Castration Resistant Prostate Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease